Mencucci Rita, Romualdi Giovanni, Carnicci Alberto, Panini Fabio, Buzzi Matilde, Giansanti Fabrizio
Eye Clinic, Department of Neuroscience, Psychology, Pharmacology and Child Health (NEUROFARBA), University of Florence, Largo Brambilla 3, 50134 Florence, Italy.
Unit of Ophthalmology, Department of Medicine, Surgery and Neuroscience, University of Siena, Viale Mario Bracci 16, 53100 Siena, Italy.
J Clin Med. 2025 Aug 18;14(16):5831. doi: 10.3390/jcm14165831.
: The Tecnis Eyhance is an enhanced monofocal intraocular lens (IOL) designed to improve intermediate vision without compromising distance clarity or increasing the incidence of photic phenomena. Although short-term results have been encouraging, long-term data remain limited. This study presents the 5-year follow-up of a previously published 6-month clinical evaluation, aiming to assess the stability of visual, optical, and patient-reported outcomes over time. : A single-center retrospective study of 18 patients (36 eyes) undergoing bilateral Tecnis Eyhance IOL implantation was conducted. The same cohort from the original 6-month study was re-evaluated after a mean follow-up of 5 years. Visual acuity (distance, intermediate, near), defocus curves, contrast sensitivity, optical quality, effective lens position (ELP), halo size, and patient-reported measures were assessed. : Visual acuity remained stable across all distances, with binocular uncorrected intermediate visual acuity (UIVA) ≤ 0.2 logMAR in all patients. No significant changes were observed in optical quality parameters or contrast sensitivity. ELP remained consistent over time ( = 0.298), and posterior capsule opacification (PCO) requiring Nd:YAG capsulotomy developed in 5% of the eyes. Halo size was mild, and subjective glare perception did not increase. Spectacle independence remained high for distance (100%) and intermediate (more than 75%) tasks. : This 5-year follow-up study confirms the long-term stability and effectiveness of the Tecnis Eyhance IOL. These findings support its long-term use as a stable monofocal IOL with enhanced intermediate function.
Tecnis Eyhance是一种增强型单焦点人工晶状体(IOL),旨在改善中距离视力,同时不影响远视力清晰度或增加光学现象的发生率。尽管短期结果令人鼓舞,但长期数据仍然有限。本研究展示了对先前发表的6个月临床评估的5年随访结果,旨在评估视觉、光学和患者报告结果随时间的稳定性。
对18例(36只眼)接受双侧Tecnis Eyhance人工晶状体植入的患者进行了单中心回顾性研究。对原始6个月研究中的同一队列进行了平均5年的随访后重新评估。评估了视力(远、中、近)、散焦曲线、对比敏感度、光学质量、有效晶状体位置(ELP)、光晕大小和患者报告的指标。
所有距离的视力均保持稳定,所有患者的双眼未矫正中距离视力(UIVA)≤0.2 logMAR。光学质量参数或对比敏感度未观察到显著变化。ELP随时间保持一致( = 0.298),5%的眼睛发生了需要钕:钇铝石榴石囊切开术的后囊膜混浊(PCO)。光晕大小较轻,主观眩光感未增加。在远距离(100%)和中距离(超过75%)任务中,不依赖眼镜的比例仍然很高。
这项5年随访研究证实了Tecnis Eyhance人工晶状体的长期稳定性和有效性。这些发现支持将其长期用作具有增强中距离功能的稳定单焦点人工晶状体。